DOX Quote, Financials, Valuation and Earnings

CDW Corp. has a net margin of 8.28% compared to Amdocs Ltd.'s net margin of 5.07%. Amdocs Ltd.'s return on equity of 16.07% beat CDW Corp.'s return on equity of 43.69%.

Amdocs Ltd. has a consensus price target of $102.50, signalling upside risk potential of 24%. On the other hand CDW Corp. has an analysts' consensus of $173.80 which suggests that it could grow by 37.94%. Given that CDW Corp. has higher upside potential than Amdocs Ltd., analysts believe CDW Corp. is more attractive than Amdocs Ltd..

Amdocs Ltd. has a beta of 0.404, which suggesting that the stock is 59.615% less volatile than S&P 500. In comparison CDW Corp. has a beta of 1.077, suggesting its more volatile than the S&P 500 by 7.675%.

Amdocs Ltd. has a quarterly dividend of $0.53 per share corresponding to a yield of 2.55%. CDW Corp. offers a yield of 1.99% to investors and pays a quarterly dividend of $0.63 per share. Amdocs Ltd. pays 40.77% of its earnings as a dividend. CDW Corp. pays out 31.17% of its earnings as a dividend. Both of these payout ratios are sufficient to cover dividend payouts with earnings for the foreseeable future.

Amdocs Ltd. quarterly revenues are $1.2B, which are smaller than CDW Corp. quarterly revenues of $5.7B. Amdocs Ltd.'s net income of $95.3M is lower than CDW Corp.'s net income of $291M. Notably, Amdocs Ltd.'s price-to-earnings ratio is 16.36x while CDW Corp.'s PE ratio is 15.94x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Amdocs Ltd. is 2.02x versus 0.76x for CDW Corp.. Usually stocks with elevated PS ratios are considered overvalued.

Concentrix Corp. has a net margin of 8.28% compared to Amdocs Ltd.'s net margin of -57.95%. Amdocs Ltd.'s return on equity of 16.07% beat Concentrix Corp.'s return on equity of -33.14%.

Amdocs Ltd. has a consensus price target of $102.50, signalling upside risk potential of 24%. On the other hand Concentrix Corp. has an analysts' consensus of $62.20 which suggests that it could grow by 43.92%. Given that Concentrix Corp. has higher upside potential than Amdocs Ltd., analysts believe Concentrix Corp. is more attractive than Amdocs Ltd..

Amdocs Ltd. has a beta of 0.404, which suggesting that the stock is 59.615% less volatile than S&P 500. In comparison Concentrix Corp. has a beta of 0.482, suggesting its less volatile than the S&P 500 by 51.772%.

Amdocs Ltd. has a quarterly dividend of $0.53 per share corresponding to a yield of 2.55%. Concentrix Corp. offers a yield of 3.14% to investors and pays a quarterly dividend of $0.36 per share. Amdocs Ltd. pays 40.77% of its earnings as a dividend. Concentrix Corp. pays out 33.39% of its earnings as a dividend. Both of these payout ratios are sufficient to cover dividend payouts with earnings for the foreseeable future.

Amdocs Ltd. quarterly revenues are $1.2B, which are smaller than Concentrix Corp. quarterly revenues of $2.6B. Amdocs Ltd.'s net income of $95.3M is higher than Concentrix Corp.'s net income of -$1.5B. Notably, Amdocs Ltd.'s price-to-earnings ratio is 16.36x while Concentrix Corp.'s PE ratio is 8.55x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Amdocs Ltd. is 2.02x versus 0.28x for Concentrix Corp.. Usually stocks with elevated PS ratios are considered overvalued.

Intellinetics, Inc. has a net margin of 8.28% compared to Amdocs Ltd.'s net margin of -9.24%. Amdocs Ltd.'s return on equity of 16.07% beat Intellinetics, Inc.'s return on equity of -15.79%.

Amdocs Ltd. has a consensus price target of $102.50, signalling upside risk potential of 24%. On the other hand Intellinetics, Inc. has an analysts' consensus of $14.50 which suggests that it could grow by 81.25%. Given that Intellinetics, Inc. has higher upside potential than Amdocs Ltd., analysts believe Intellinetics, Inc. is more attractive than Amdocs Ltd..

Amdocs Ltd. has a beta of 0.404, which suggesting that the stock is 59.615% less volatile than S&P 500. In comparison Intellinetics, Inc. has a beta of 0.232, suggesting its less volatile than the S&P 500 by 76.847%.

Amdocs Ltd. has a quarterly dividend of $0.53 per share corresponding to a yield of 2.55%. Intellinetics, Inc. offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Amdocs Ltd. pays 40.77% of its earnings as a dividend. Intellinetics, Inc. pays out -- of its earnings as a dividend. Amdocs Ltd.'s payout ratio is sufficient to cover dividend payouts with earnings for the foreseeable future.

Amdocs Ltd. quarterly revenues are $1.2B, which are larger than Intellinetics, Inc. quarterly revenues of $4M. Amdocs Ltd.'s net income of $95.3M is higher than Intellinetics, Inc.'s net income of -$369.8K. Notably, Amdocs Ltd.'s price-to-earnings ratio is 16.36x while Intellinetics, Inc.'s PE ratio is 248.75x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Amdocs Ltd. is 2.02x versus 2.07x for Intellinetics, Inc.. Usually stocks with elevated PS ratios are considered overvalued.

WidePoint Corp. has a net margin of 8.28% compared to Amdocs Ltd.'s net margin of -1.55%. Amdocs Ltd.'s return on equity of 16.07% beat WidePoint Corp.'s return on equity of -17.34%.

Amdocs Ltd. has a consensus price target of $102.50, signalling upside risk potential of 24%. On the other hand WidePoint Corp. has an analysts' consensus of $9.33 which suggests that it could grow by 33.72%. Given that WidePoint Corp. has higher upside potential than Amdocs Ltd., analysts believe WidePoint Corp. is more attractive than Amdocs Ltd..

Amdocs Ltd. has a beta of 0.404, which suggesting that the stock is 59.615% less volatile than S&P 500. In comparison WidePoint Corp. has a beta of 1.330, suggesting its more volatile than the S&P 500 by 33.007%.

Amdocs Ltd. has a quarterly dividend of $0.53 per share corresponding to a yield of 2.55%. WidePoint Corp. offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Amdocs Ltd. pays 40.77% of its earnings as a dividend. WidePoint Corp. pays out -- of its earnings as a dividend. Amdocs Ltd.'s payout ratio is sufficient to cover dividend payouts with earnings for the foreseeable future.

Amdocs Ltd. quarterly revenues are $1.2B, which are larger than WidePoint Corp. quarterly revenues of $36.1M. Amdocs Ltd.'s net income of $95.3M is higher than WidePoint Corp.'s net income of -$559.2K. Notably, Amdocs Ltd.'s price-to-earnings ratio is 16.36x while WidePoint Corp.'s PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Amdocs Ltd. is 2.02x versus 0.46x for WidePoint Corp.. Usually stocks with elevated PS ratios are considered overvalued.